Clinical Trial Update: Pilot Study of 18F Fluoropaclitaxel (FPAC) [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating 18F Fluoropaclitaxel (FPAC) in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 18F Fluoropaclitaxel (FPAC) (fluoropaclitaxel)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Breast Cancer | EARLY_Phase 1 | Status: COMPLETED